Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Mar. 27, 2022	Mar. 28, 2021
Cash flows from operating activities:
Net earnings	$ 62.9	$ 117.5
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation of plant and equipment	25.1	25.0
Amortization of intangibles	27.1	32.9
Program cost amortization	138.5	97.5
Deferred income taxes	(33.4)	16.3
Stock-based compensation	18.1	16.7
Other non-cash items	3.9	5.4
Change in operating assets and liabilities net of acquired balances:
Decrease in accounts receivable	559.8	592.0
Increase in inventories	(99.6)	(42.1)
Decrease in prepaid expenses and other current assets	42.1	44.9
Program spend, net	(169.4)	(147.1)
Decrease in accounts payable and accrued liabilities	(464.4)	(382.6)
Other	24.0	1.2
Net cash provided by operating activities	134.7	377.6
Cash flows from investing activities:
Additions to property, plant and equipment	(29.2)	(23.9)
Other	5.3	(1.6)
Net cash utilized by investing activities	(23.9)	(25.5)
Cash flows from financing activities:
Proceeds from borrowings with maturity greater than three months	1.3	72.4
Repayments of borrowings with maturity greater than three months	(133.9)	(344.9)
Net proceeds from other short-term borrowings	103.3	2.0
Stock-based compensation transactions	70.2	4.7
Dividends paid	(94.5)	(93.4)
Payments related to tax withholding for share-based compensation	(19.3)	(9.3)
Other	(4.6)	(2.3)
Net cash utilized by financing activities	(77.5)	(370.8)
Effect of exchange rate changes on cash	5.4	(0.6)
Net increase (decrease) in cash, cash equivalents and restricted cash	38.7	(19.3)
Cash, cash equivalents and restricted cash at beginning of year	1,019.2	1,449.7
Cash, cash equivalents and restricted cash at end of period	1,057.9	1,430.4
Cash paid during the period for:
Interest	30.5	34.5
Income taxes	$ 29.2	$ 18.3